- Live market news
- Stocks
- VEEV
Veeva Systems Inc Class A
VEEVStockUSA
Veeva Systems Inc Class A
Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud computing software, data, and consulting services for the life sciences industry. Its products are used to track all aspects of drug development and pharmaceutical manufacturing.
The company has 1,552 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia.
Key figures
- Previous close
- 318.18
- Open
- 315.50
- Day range
- 310.50 – 318.51
- 52-week range
- —
- Volume
- 1.36M
Latest news on VEEVranked by Oyticker for market impact
- 45Impact
Servier deploys Veeva OpenData across 80+ countries to expand AI capabilities
Servier has standardized customer reference data across 80+ countries using Veeva OpenData, expanding AI deployment in pharmaceutical operations.
VEEVSoftware / SaaSLife Sciences / Pharmaceuticals - 62Impact
Servier deploys Veeva OpenData across 80+ countries for AI-scale customer data standardization
Servier, a major pharmaceutical company, has standardized customer master data across 80+ countries using Veeva OpenData, enabling large-scale AI deployment. This represents a significant enterprise adoption of Veeva's data platform.
VEEVSoftwareLife Sciences & PharmaceuticalsEnterprise Data Management - 62Impact
Servier deploys Veeva OpenData globally across 80+ countries
Servier has standardized customer reference data across 80+ countries using Veeva's OpenData platform, expanding the pharmaceutical company's data infrastructure for AI scaling.
VEEVSoftware & SaaSLife Sciences & PharmaData & Analytics - 55Impact
Servier deploys Veeva OpenData across 80+ countries for AI scaling
Veeva Systems announced Servier, a major pharmaceutical company, is standardizing customer reference data globally using Veeva OpenData to support AI initiatives. This represents a multi-country enterprise deployment of Veeva's data platform.
VEEVSoftware & SaaSLife Sciences / Pharmaceuticals
In detailthe same figures as in Oyticker Charts
Performance
Ranges & volume
- Open
- 315.50
- Prev. close
- 318.18
Risk · 1 year
Seasonality
What VEEV filed
- 5 Nov 2026
- 27 Aug 2026
- 26 Aug 2026
- 20 Aug 2026
- 18 Jun 2026
- 5 Jun 2026
- 3 Jun 2026
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.